• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Idenix Pharmaceuticals Inc

NO9:GR

Ticker Delisted

As of 09:34:15 ET on 08/05/2014.

Snapshot for Idenix Pharmaceuticals Inc (NO9)

Open: - Day's Range: - Volume: 0
Previous Close: - 52wk Range: 2.260 - 18.105 1-Yr Rtn: -

Stock Chart for NO9

No chart data available.
  • NO9:GR 18.105
  • 1D
  • 1M
  • 1Y
0.000
Interactive NO9 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NO9

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.9600
Est. PEG Ratio -
Market Cap (M EUR) 0.00
Shares Outstanding (M) 0.00
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NO9

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for NO9

Idenix Pharmaceuticals Inc. is a biopharmaceutical company that discovers and develops drugs for the treatment of human viral and other infectious diseases. The Company is focusing on the treatment of infections caused by hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV).

Douglas MayersExec VP/Chief Medical OfficerJacques DumasExec VP/Chief Scientific Ofcr
Daniella BeckmanSenior VP/CFO/TreasurerMaria D StahlSenior VP/Secy/General Counsel
More Company Profile & Key Executives for NO9

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil